Table 2.
Patient characteristics | Relative risk | 95% CI | p value |
---|---|---|---|
Sex | |||
Male | Reference | ||
Female | 0.33 | 0.93 | 0.32 |
Age group (years) | |||
18–29 | 0.91 | 1.03 | 0.91 |
30–39 | 0.76 | 1.07 | 0.75 |
40–49 | 0.77 | 0.93 | 0.77 |
50–59 | 0.39 | 0.80 | 0.39 |
60–69 | 0.80 | 1.06 | 0.80 |
≥ 70 | Reference | ||
Biologic history | |||
Yes | Reference | ||
No | 1.26 | 1.00–1.60 | 0.05 |
Region | |||
Ontario | 0.05 | 0.83 | 0.04 |
Québec | Reference | ||
East | 0.66 | 0.93 | 0.66 |
Unknown | 0.61 | 0.87 | 0.61 |
Disease control at baseline (initial BASDAI) | |||
Controlled | 1.82 | 1.26–2.62 | 0.0013 |
Not controlled | Reference | ||
Days lapsed, median days (IQR) | 1.00 | 1.00–1.00 | 0.39 |
Disease control (follow-up BASDAI) | |||
Controlled | 1.23 | 1.06–1.42 | 0.0055 |
Not controlled | Reference |
The comparison of cohort characteristics was performed using Poisson regression, with robust error variance adjusting for age, sex, region, biologics-naïve status, disease control status at baseline, and number of days between assessments
BASDAI Bath Ankylosing Spondylitis Disease Activity Index, CCC care coach call, CI confidence interval, IQR interquartile range, PSP patient support program